Italy reports stem-cell achievement

Jun 29, 2006

Italian scientists say the stem cells they extracted from "virgin birth" embryos are capable of turning into neurons.

The University of Milan researchers said the embryos were produced by a process called parthenogenesis, which allows eggs to develop without being fertilized.

The technique might allow embryonic stem cells to be produced without having to destroy an early stage human embryo made by fertilizing eggs with sperm, the Brisbane (Australia) Herald Sun reported.

Human "parthenotes" -- embryos made by parthenogenesis -- normally never develop beyond a few days. But the Italian researchers created parthenotes that divided and formed immature embryos called blastocysts, New Scientist magazine reported. They subsequently obtained stem cells from the embryos and grew them in the laboratory, demonstrating the cells can differentiate into mature neurons.

Monash University stem-cell expert Dr. Alan Trounson told the Herald Sun: "This is the first example I have seen of this in humans, and it is potentially very exciting. It could be a source of embryonic stem cells that's not embryonic in the conventional sense."

The findings were presented last week in the Czech Republic, during the annual meeting of the European Society for Human Reproduction and Embryology.

Copyright 2006 by United Press International

Explore further: Online illusion: Unplugged, we really aren't that smart

Related Stories

Stem cells make similar decisions to humans

Mar 25, 2015

Scientists at the University of Copenhagen have captured thousands of progenitor cells of the pancreas on video as they made decisions to divide and expand the organ or to specialize into the endocrine cells that regulate ...

Recommended for you

Will the Affordable Care Act eliminate health disparities?

30 minutes ago

Massachusetts' health reform may be a crystal ball for researchers and policymakers in forecasting the potential impact of the Affordable Care Act. Many see the ACA as the backbone of efforts toward closing the nation's health ...

Japan's Takeda offers $2.2 bn to settle US drug lawsuits

1 hour ago

Japan's top drugmaker Takeda Pharmaceutical has offered $2.2 billion to settle US claims linked to its diabetes drug Actos, in what would be one of the biggest US payouts over patient lawsuits, a report said Wednesday.

Blood test predicts severity of peanut and seafood allergies

6 hours ago

A new blood test promises to predict which people will have severe allergic reactions to foods according to a new study led by Mount Sinai researchers and published online today in the The Annals of Allergy, Asthma & Immunology.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.